» Articles » PMID: 29253007

Hypertonic Saline Attenuates the Cytokine-induced Pro-inflammatory Signature in Primary Human Lung Epithelia

Overview
Journal PLoS One
Date 2017 Dec 19
PMID 29253007
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Trauma/hemorrhagic shock is a complex physiological phenomenon that leads to dysregulation of many molecular pathways. For over a decade, hypertonic saline (HTS) has been used as an alternative resuscitation fluid in the setting of trauma/hemorrhagic shock. In addition to restoring circulating volume within the vascular space, studies have shown a positive immunomodulatory effect of HTS. Targeted studies have shown that HTS affects the transcription of several pro-inflammatory cytokines by inhibiting the NF-κB-IκB pathway in model cell lines and rats. However, few studies have been undertaken to assess the unbiased effects of HTS on the whole transcriptome. This study was designed to interrogate the global transcriptional responses induced by HTS and provides insight into the underlying molecular mechanisms and pathways affected by HTS. In this study, RNA sequencing was employed to explore early changes in transcriptional response, identify key mediators, signaling pathways, and transcriptional modules that are affected by HTS in the presence of a strong inflammatory stimulus. Our results suggest that primary human small airway lung epithelial cells (SAECS) exposed to HTS in the presence and absence of a strong pro-inflammatory stimulus exhibit very distinct effects on cellular response, where HTS is highly effective in attenuating cytokine-induced pro-inflammatory responses via mechanisms that involve transcriptional regulation of inflammation which is cell type and stimulus specific. HTS is a highly effective anti-inflammatory agent that inhibits the chemotaxis of leucocytes towards a pro-inflammatory gradient and may attenuate the progression of both the innate and adaptive immune response.

Citing Articles

Hypertonic Saline Induces Host Protective Immune Responses against Infection in Mice.

Huy T, Nguyen T, Salad S, Aguilar C, Reyes A, Arayan L J Microbiol Biotechnol. 2024; 34(11):2192-2200.

PMID: 39403730 PMC: 11637827. DOI: 10.4014/jmb.2407.07040.


Liquid application dosing alters the physiology of air-liquid interface (ALI) primary human bronchial epithelial cell/lung fibroblast co-cultures and testing relevant endpoints.

Mallek N, Martin E, Dailey L, McCullough S Front Toxicol. 2024; 5:1264331.

PMID: 38464699 PMC: 10922929. DOI: 10.3389/ftox.2023.1264331.


Effects of nebulized hypertonic saline on inflammatory mediators in patients with severe COVID-19 pneumonia: A double-blinded randomized controlled trial.

Beigmohammadi M, Amoozadeh L, Naghibi N, Eslami B, Ghazi S, Javaherian M Sci Prog. 2023; 106(4):368504231203130.

PMID: 37787398 PMC: 10548801. DOI: 10.1177/00368504231203130.


Mechanobiological Adaptation to Hyperosmolarity Enhances Barrier Function in Human Vascular Microphysiological System.

Kang J, Jang M, Seo S, Choi A, Shin D, Seo S Adv Sci (Weinh). 2023; 10(13):e2206384.

PMID: 36808839 PMC: 10161024. DOI: 10.1002/advs.202206384.


Preliminary investigation of a hypertonic saline nasal rinse as a hygienic intervention in dairy workers.

Erlandson G, Magzamen S, Sharp J, Mitra S, Jones K, Poole J J Occup Environ Hyg. 2022; 20(1):14-22.

PMID: 36260509 PMC: 10958439. DOI: 10.1080/15459624.2022.2137297.


References
1.
Garlanda C, Dinarello C, Mantovani A . The interleukin-1 family: back to the future. Immunity. 2013; 39(6):1003-18. PMC: 3933951. DOI: 10.1016/j.immuni.2013.11.010. View

2.
Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier R . Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol. 2002; 168(3):1389-96. DOI: 10.4049/jimmunol.168.3.1389. View

3.
Silva M . Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J Leukoc Biol. 2010; 87(5):805-13. DOI: 10.1189/jlb.1109767. View

4.
Iwakura Y, Ishigame H . The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006; 116(5):1218-22. PMC: 1451213. DOI: 10.1172/JCI28508. View

5.
Knight D . Leukaemia inhibitory factor (LIF): a cytokine of emerging importance in chronic airway inflammation. Pulm Pharmacol Ther. 2001; 14(3):169-76. DOI: 10.1006/pupt.2001.0282. View